The Bayh-Dole Act: Boon or Bane?
Filed in archive Patents and Intellectual Property Rights on September 15, 2005

Fortune75 runs a lengthy article on the Bayh-Dole Act or Patent and Trademark Ammendments Act, which promoted the participation of universities and federally funded institution in the commercialization of their patentable discoveries and inventions.
An excerpt:
"On the face of it, Bayh-Dole makes sense. Indeed, supporters say the law helped create the $43-billion-a-year biotech industry and has brought valuable drugs to market that otherwise would never have seen the light of day. What's more, say many scholars, the law has created megaclusters of entrepreneurial companies---each an engine for high-paying, high-skilled jobs---all across the land.
That all sounds wonderful. Except that Bayh-Dole's impact wasn't so much in the industry it helped create, but rather in its unintended consequence---a legal frenzy that's diverting scientists from doing science."
Read the full story here.

That all sounds wonderful. Except that Bayh-Dole's impact wasn't so much in the industry it helped create, but rather in its unintended consequence---a legal frenzy that's diverting scientists from doing science."
Permalink: The Bayh-Dole Act: Boon or Bane?
Tags: patent IPR biotech dole bayh bayh+dole boon+bane dole+boon
Vote for The Bayh-Dole Act: Boon or Bane?:
|
Rating: 9.33 out of 3 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
